COVAXIS

This brand name is authorized in Lithuania

Active ingredients

The drug COVAXIS contains a combination of these active pharmaceutical ingredients (APIs):

1 Diphtheria toxoid
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
Read about Diphtheria toxoid
2 Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid
3 Pertussis toxoid
Read about Pertussis toxoid
4 Pertussis filamentous hemagglutinin
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Pertussis filamentous hemagglutinin
5 Pertactin
UNII 2QNL82089R - BORDETELLA PERTUSSIS
Read about Pertactin
6 Fimbriae Types 2 and 3
Read about Pertussis toxoid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07AJ52 Pertussis, purified antigen, combinations with toxoids J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AJ Pertussis vaccines
Discover more medicines within J07AJ52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1086022

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈